Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
27 Apr 2024, 12:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
ECHS CFA RE 10
6292476
GEM/2024/B/4843464
Two Packet Bid
Phenobarbitone 30 mg Tab,Pioglitazone Hydrochloride 15 mg Tab,Piracetam 800mg Tab,Pramipexole 0.25
30 days
Uttarakhand; Dehradun
Item wise evaluation
BOQ
6 documents required · 6 mandatory
Exempted
27 Apr 2024
6 Apr 2024
27 Apr 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Phenobarbitone 30 mg Tab | 4,680 | No | DEHRADUN | 30 |
| 2 | Pioglitazone Hydrochloride 15 mg Tab | 42,480 | No | DEHRADUN | 30 |
| 3 | Piracetam 800mg Tab | 19,020 | No | DEHRADUN | 30 |
| 4 | Pramipexole 0.25 mg Tab | 3,600 | No | DEHRADUN | 30 |
| 5 | Pramipexole 0.5mg Tab | 5,400 | No | DEHRADUN | 30 |
| 6 | Prasugrel HCL 5mg Tab | 2,700 | No | DEHRADUN | 30 |
| 7 | Prasugrel 10mg Tab | 4,500 | No | DEHRADUN | 30 |
| 8 | Prednisolone 10 mg Tab | 11,760 | No | DEHRADUN | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6292476.pdf
GEM_BID
re_10_2024-04-06-09-26-37_0d1154a69ece7ce7218ace154b810ebc.pdf
BOQ
boq_item_sample_10_2024-04-06-09-26-37_58f07443416c5b0275b339f4e3883b50.csv
BOQ
Undertking_3b9583b8-a996-4b6b-b9a61712376286734_hempreet@1234.docx
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .